The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec

Human Immunology

Volumn 74, Issue 12, 2013, Pages 1610-1615

  Metcalfe, Stephanie ^a   Roger, Michel ^b   Faucher, Marie Claude ^b   Coutlée, François ^a,b   Franco, Eduardo L ^a   Brassard, Paul ^a  

^a MCGILL UNIVERSITY   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ALLELE; ANTIGEN RECOGNITION; ARTICLE; CANADA; DNA POLYMORPHISM; DNA SEQUENCE; ESKIMO; FEMALE; GENOTYPE; HIGH RISK PATIENT; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; PERSISTENT INFECTION; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY;

ALLELES; ALPHAPAPILLOMAVIRUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY TESTING; HLA-G ANTIGENS; HUMANS; INUITS; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; QUEBEC;

EID: 84888200690     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.08.279     Document Type: Article

References (36)

1. Trottier H., Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine 2006, 24(Suppl 1):S1.
2. Baseman J.G., Koutsky L.A. The epidemiology of human papillomavirus infections. J Clin Virol 2005, 32(Suppl 1):S16.
3. Tota J.E., Chevarie-Davis M., Richardson L.A., Devries M., Franco E.L. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med 2011, 53(Suppl 1):S12.
4. TSoOaGoC, Incidence and prevalence of HPV in Canada. .
5. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12.
6. Franco E.L., Villa L.L., Sobrinho J.P., Prado J.M., Rousseau M.C., Desy M., et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999, 180:1415.
7. Hildesheim A., Wang S.S. Host and viral genetics and risk of cervical cancer: a review. Virus Res 2002, 89:229.
8. Chattopadhyay K. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet 2011, 17:132.
9. de Araujo Souza P.S., Sichero L., Maciag P.C. HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future oncol 2009, 5:359.
10. Ferguson R., Ramanakumar A.V., Koushik A., Coutlee F., Franco E., Roger M. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. Int J Cancer 2012, 131:3.
11. Ferguson R., Ramanakumar A.V., Richardson H., Tellier P.P., Coutlee F., Franco E.L., et al. Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. Hum Immunol 2011, 72:337.
12. Simoes R.T., Goncalves M.A., Castelli E.C., Junior C.M., Bettini J.S., Discorde M.L., et al. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Mod pathol 2009, 22:1075.
13. Pistoia V., Morandi F., Wang X., Ferrone S. Soluble HLA-G: Are they clinically relevant?. Semin Cancer Biol 2007, 17:469.
14. Bourgault Villada I., Moyal Barracco M., Berville S., Bafounta M.L., Longvert C., Premel V., et al. Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins. Clin Exp Immunol 2010, 159:45.
15. Valdespino V., Gorodezky C., Ortiz V., Kaufmann A.M., Roman-Basaure E., Vazquez A., et al. HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients. Gynecol Oncol 2005, 96:92.
16. Fainardi E., Castellazzi M., Stignani M., Morandi F., Sana G., Gonzalez R., et al. Emerging topics and new perspectives on HLA-G. Cell Mol Life Sci 2011, 68:433.
17. Sheu J., Shih Ie M. HLA-G and immune evasion in cancer cells. J Formos Med Assoc 2010, 109:248.
18. Guimaraes M.C., Soares C.P., Donadi E.A., Derchain S.F., Andrade L.A., Silva T.G., et al. Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV). J Histochem Cytochem 2010, 58:405.
19. Fregonezi P.A., Silva T.G., Simoes R.T., Moreau P., Carosella E.D., Klay C.P. Expression of nonclassical molecule human leukocyte antigen-G in oral lesions. Am J Otolaryngol 2012, 33:193.
20. Dong D.D., Yang H., Li K., Xu G., Song L.H., Fan X.L. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response. Reprod Sci 2010, 17:718.
21. Hamlin-Douglas L.K., Coutlee F., Roger M., Franco E.L., Brassard P. Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec. Cancer Epidemiol Biomarkers Prev 2008, 17:3141.
22. Hamlin-Douglas L.K., Coutlee F., Roger M., Hanley J., Franco E.L., Brassard P. Determinants of human papillomavirus infection among Inuit women of northern Quebec, Canada. Sex Transm Dis 2010, 37:377.
23. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., Zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17.
24. Mahmud S.M., Robinson K., Richardson H., Tellier P.P., Ferenczy A.S., Roger M., et al. HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students. J Infect Dis 2007, 196:82.
25. Chaturvedi A.K., Katki H.A., Hildesheim A., Rodriguez A.C., Quint W., Schiffman M., et al. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 2011, 203:910.
26. Levi J.E., Kleter B., Quint W.G., Fink M.C., Canto C.L., Matsubara R., et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002, 40:3341.
27. Cervantes J.L. Multiple human papillomavirus infection: don't forget the genetic background. J Infect Dis 2011, 204:1816. author reply 1816.
28. Smith MA. Occurrence, Determinants and Dynamics of HPV Coinfections in a Cohort of Montreal University Students. Department of Community Health and Epidemiology vol MSc, Queen's University, 2011.
29. Woodman C.B., Collins S.I., Young L.S. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007, 7:11.
30. Donadi E.A., Castelli E.C., Arnaiz-Villena A., Roger M., Rey D., Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011, 68:369.
31. Silva I.D., Muniz Y.C., Sousa M.C., Silva K.R., Castelli E.C., Filho J.C., et al. HLA-G 3'UTR polymorphisms in high grade and invasive cervico-vaginal cancer. Hum Immunol 2013, 74:452.
32. Bicalho Mda G., Fiano V., Grasso C., TaralloDe Marco Let al V., De Marco L., et al. Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis. BMC cancer 2012, 12:618.
33. Metcalfe S., Roger M., Faucher M.-C., Coutlée F., Franco E.L., Brassard P. The frequency of HLA alleles in a population of Inuit women of northern Quebec. Int J Circumpolar Health 2013, 72:21350. .
34. Canada S. Aboriginal Population Profile Region du Nunavik 2006. .
35. Rochette MAaL. Nunavik Inuit Health Survey 2004. Qanuippitaa? How are we?, Institut national de santé publique du Québec (INSPQ) & Nunavik Regional Board of Health and Social Services (NRBHSS), 2008.
36. Sylvie Dodin, Louis Rochette. Women's Health and Preventive Sexual Behaviour Among Men and Women. Qanuippitaa? How are we?, Institut national de santé publique du Québec (INSPQ) & Nunavik Regional Board of Health and Social Services (NRBHSS), 2007.